Compare Figma Inc. Class A Common Stock (FIG) vs Indivior Pharmaceuticals Inc. Common Stock (INDV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Figma Inc. Class A Common Stock vs Indivior Pharmaceuticals Inc. Common Stock — how do they compare? Figma Inc. Class A Common Stock trades at $21.43 (market cap $11.60B), while Indivior Pharmaceuticals Inc. Common Stock trades at $34.01 (market cap $4.18B). The key difference: Figma Inc. Class A Common Stock is far larger — about 2.8× Indivior Pharmaceuticals Inc. Common Stock's market cap, and Indivior Pharmaceuticals Inc. Common Stock is trading nearer its 52-week high, Figma Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Figma Inc. Class A Common Stock for 0 Days and Indivior Pharmaceuticals Inc. Common Stock for 0 Days on average.
| FIG | INDV | |
|---|---|---|
Market Cap | $11.60B | $4.18B |
Volume | 12,281,013 | 1,819,746 |
Sector | Technology | Health |
52-Week High | $63.82 | $41.83 |
52-Week Low | $16.84 | $24.09 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.00B | $4.47B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Figma Inc. Class A Common Stock
Figma, Inc. is a US software company that operates a collaborative interface design and product development platform used by design and engineering teams to create, prototype, and build digital products.
Read more on FIG →About Indivior Pharmaceuticals Inc. Common Stock
Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.
Read more on INDV →
